Home » Topics » Disease categories and therapies » Urology

Urology
RSS

European approval for Avodart for benign prostatic hyperplasia

Dec. 11, 2002

Lilly and Boehringer Ingelheim sign cocommercialization agreements for duloxetine

Dec. 10, 2002

Lilly Icos presents new PDE5 inhibitors for male and female sexual dysfunction

Dec. 9, 2002

Marketing authorization application submitted for Striant in U.K.

Dec. 9, 2002

ZP-120 completes phase I trial

Dec. 9, 2002

Kissei licenses KUC-7483 to Boehringer Ingelheim

Dec. 2, 2002

Ortho Biotech licenses bone morphogenetic protein technology

Nov. 29, 2002

Effective agents for nephritis without cardiovascular side effects designed at Tanabe Seiyaku

Nov. 28, 2002

Renoprotective effects of ALT-711 in diabetic rats

Nov. 27, 2002

Potential use of pirfenidone in progressive renal disease

Nov. 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...